LBP and hepatocellular carcinoma: Zhang et al [26] found that LBP could block human hepatoma SMMC-7721 cells at the G0/G1 and S phases with an inhibition ratio of 45.13%, showing that LBP can be provided as a potential chemotherapeutic agent drug to treat cancer.